시장보고서
상품코드
1937910

대동맥판 치환 기기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Aortic Valve Replacement Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034

발행일: | 리서치사: Value Market Research | 페이지 정보: 영문 162 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

대동맥판 치환 기기 시장 규모는 2025년 84억 달러에서 2034년에는 209억 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 10.66%로 성장할 전망입니다.

대동맥판막 치환기기 시장은 대동맥판막 협착증 유병률 증가와 전 세계 고령화를 배경으로 큰 폭의 성장이 예상됩니다. 심혈관질환이 지속적으로 증가함에 따라 효과적이고 최소침습적인 치료법에 대한 수요가 매우 중요해지고 있습니다. 대동맥판막치환술, 특히 경피적 대동맥판막치환술(TAVR)은 기존 수술법에 비해 회복기간이 짧으면서도 눈에 띄는 임상적 이점을 제공할 수 있어 주목받고 있습니다.

밸브 설계 및 전달 시스템의 기술적 발전으로 대동맥 판막 치환술의 안전성과 유효성이 향상되고 있습니다. 생체 판막과 혁신적인 소재의 개발은 환자의 치료 결과를 개선하고, 이러한 개입의 혜택을 받을 수 있는 환자의 적응증 기준을 확대하고 있습니다. 또한, 환자 중심 치료에 대한 관심이 높아짐에 따라 내구성과 성능이 향상된 기기에 대한 수요가 증가하여 판막 치환술의 장기적인 성공을 보장합니다.

또한, 심혈관 건강 상태와 조기 진단의 중요성에 대한 인식이 높아지면서 대동맥 판막 치환 기기 시장의 성장에 기여하고 있습니다. 의료진이 심장 질환의 적극적인 관리에 집중함에 따라 고급 진단 도구 및 치료 옵션에 대한 수요가 증가할 것으로 예상됩니다. 원격 모니터링 및 원격의료와 같은 디지털 헬스 기술의 통합은 환자 참여와 사후 관리를 강화하여 시장 확대를 더욱 촉진하고 있습니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 대동맥판 치환 기기 시장 : 제품별

제5장 세계의 대동맥판 치환 기기 시장 : 리플릿 소재별

제6장 세계의 대동맥판 치환 기기 시장 : 프레임 소재별

제7장 세계의 대동맥판 치환 기기 시장 : 최종 용도별

제8장 세계의 대동맥판 치환 기기 시장 : 지역별

제9장 경쟁 구도

제10장 기업 개요

KSM 26.03.24

The Aortic Valve Replacement Devices Market size is expected to reach USD 20.90 Billion in 2034 from USD 8.40 Billion (2025) growing at a CAGR of 10.66% during 2026-2034.

The aortic valve replacement devices market is set for substantial growth, driven by the increasing prevalence of aortic stenosis and the aging global population. As cardiovascular diseases continue to rise, the demand for effective and minimally invasive treatment options is becoming paramount. Aortic valve replacement procedures, particularly transcatheter aortic valve replacement (TAVR), are gaining traction due to their ability to provide significant clinical benefits with reduced recovery times compared to traditional surgical approaches.

Technological advancements in valve design and delivery systems are enhancing the safety and efficacy of aortic valve replacement procedures. The development of bioprosthetic valves and innovative materials is improving patient outcomes and expanding the eligibility criteria for patients who may benefit from these interventions. Additionally, the growing emphasis on patient-centered care is driving the demand for devices that offer improved durability and performance, ensuring long-term success in valve replacement.

Furthermore, the increasing awareness of cardiovascular health and the importance of early diagnosis are contributing to the growth of the aortic valve replacement devices market. As healthcare providers focus on proactive management of heart conditions, the demand for advanced diagnostic tools and treatment options is expected to rise. The integration of digital health technologies, such as remote monitoring and telemedicine, is also enhancing patient engagement and follow-up care, further supporting the market's expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Balloon-expandable
  • Self-expandable
  • Mechanically Expandable
  • Aortic Regurgitation

By Leaflet Material

  • Bovine Pericardium
  • Porcine Pericardium

By Frame Material

  • Cobalt-Chromium
  • Nitinol
  • Others

By End-Use

  • Inpatient Facilities
  • Outpatient Facilities

COMPANIES PROFILED

  • Boston Scientific Corporation, Artivion, Inc, LivaNova PLC, Abbott, Comp7, Medtronic, Edwards Lifesciences Corporation, Cryolife, Inc, JenavValve Technology, Inc, Micro Interventional Devices, Braile Biomedica

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Balloon-expandable Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Self-expandable Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Mechanically Expandable Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Aortic Regurgitation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY LEAFLET MATERIAL 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Leaflet Material
  • 5.2. Bovine Pericardium Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Porcine Pericardium Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY FRAME MATERIAL 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Frame Material
  • 6.2. Cobalt-Chromium Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Nitinol Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY END-USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-use
  • 7.2. Inpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Outpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Leaflet Material
    • 8.2.3 By Frame Material
    • 8.2.4 By End-use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Leaflet Material
    • 8.3.3 By Frame Material
    • 8.3.4 By End-use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Leaflet Material
    • 8.4.3 By Frame Material
    • 8.4.4 By End-use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Leaflet Material
    • 8.5.3 By Frame Material
    • 8.5.4 By End-use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Leaflet Material
    • 8.6.3 By Frame Material
    • 8.6.4 By End-use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL AORTIC VALVE REPLACEMENT DEVICES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Boston Scientific Corporation
    • 10.2.2 Artivion, Inc
    • 10.2.3 LivaNova PLC
    • 10.2.4 Abbott
    • 10.2.5 Comp7
    • 10.2.6 Medtronic
    • 10.2.7 Edwards Lifesciences Corporation
    • 10.2.8 CryolifeInc
    • 10.2.9 JenavValve TechnologyInc
    • 10.2.10 Micro Interventional Devices
    • 10.2.11 Braile Biomedica
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제